© 2019 Thriwing Capital Corp. | English |

Privacy Legal

Health Burdens in China

China’s demand for high-end healthcare services and products, as well as advanced medical devices to treat chronic diseases and take care of their elder population has increased rapidly over the past few years. Unsurprisingly, China is already the world’s second largest market for medical equipment, and healthcare spending is expected to constitute 6.5-7 percent of the country’s GDP by 2020.


China’s healthcare market is growing rapidly, with annual expenditures projected to reach $896.7 billion by 2019, up from an estimated $579.7 billion in 2014. Strong growth in the healthcare sector is fueled by favorable demographic trends, continuing urbanization, an increasing disease burden, the overall economy’s healthy expansion, and income growth (which encourages greater awareness of and access to treatments).

In order to tap into this demand, Chinese companies have been stepping up their overseas investment in the healthcare sector in North American companies. Their objective is to access technology, expertise and high-quality brands that can be adapted to satisfy the needs of the Chinese market.

Subsector Focus
  • Diagnostics

  • Pharmaceuticals

  • Medical Devices

  • Healthcare IT

  • Biotechnology

  • Life Science Tools

  • Senior Living

  • Rehabilitation

What we look for
  • Proprietary IP

  • Product ready for commercialization

  • Strong scientific team & R&D capabilities

  • Joint R&D